Alto Neuroscience Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANRO and other ETFs, options, and stocks.

About ANRO

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. 

CEO
Amit Etkin
CEOAmit Etkin
Employees
76
Employees76
Headquarters
Mountain View, California
HeadquartersMountain View, California
Founded
2019
Founded2019
Employees
76
Employees76

ANRO Key Statistics

Market cap
61.21M
Market cap61.21M
Price-Earnings ratio
-0.97
Price-Earnings ratio-0.97
Dividend yield
Dividend yield
Average volume
217.31K
Average volume217.31K
High today
$2.33
High today$2.33
Low today
$2.21
Low today$2.21
Open price
$2.23
Open price$2.23
Volume
138.73K
Volume138.73K
52 Week high
$17.55
52 Week high$17.55
52 Week low
$1.60
52 Week low$1.60

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ANRO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.